Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Preexposure prophylaxis reduces HIV risk in injection-drug users.

Rosenberg K.

Am J Nurs. 2013 Sep;113(9):17. doi: 10.1097/01.NAJ.0000434163.23256.f7. No abstract available.

PMID:
23985594
[PubMed - indexed for MEDLINE]
2.

Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 Jun 14;62(23):463-5.

PMID:
23760186
[PubMed - indexed for MEDLINE]
Free Article
3.

[Preexposure prophylaxis for HIV infection--current data and recommendations].

Kümmerle T, Fätkenheuer G.

Dtsch Med Wochenschr. 2012 Nov;137(44):2285-8. doi: 10.1055/s-0032-1327234. Epub 2012 Oct 23. German. No abstract available.

PMID:
23093400
[PubMed - indexed for MEDLINE]
4.

[Pre-exposure prophylaxis for HIV transmission? No, unless].

Boeke AJ, Heijnen AM.

Ned Tijdschr Geneeskd. 2013;157(27):A6359. Dutch.

PMID:
23838404
[PubMed - indexed for MEDLINE]
5.

Concentrations of tenofovir and emtricitabine in saliva: implications for preexposure prophylaxis of oral HIV acquisition.

de Lastours V, Fonsart J, Burlacu R, Gourmel B, Molina JM.

Antimicrob Agents Chemother. 2011 Oct;55(10):4905-7. doi: 10.1128/AAC.00120-11. Epub 2011 Jul 25.

PMID:
21788466
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.

Chi BH, Ellis GM, Chintu N, Cantrell RA, Sinkala M, Aldrovandi GM, Warrier R, Mbewe F, Nakamura K, Stringer EM, Frenkel LM, Stringer JS.

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1099-106. doi: 10.1089/aid.2009.0088.

PMID:
19886836
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice.

Denton PW, Krisko JF, Powell DA, Mathias M, Kwak YT, Martinez-Torres F, Zou W, Payne DA, Estes JD, Garcia JV.

PLoS One. 2010 Jan 21;5(1):e8829. doi: 10.1371/journal.pone.0008829.

PMID:
20098623
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Antiretroviral prophylaxis: a defining moment in HIV control.

Karim SS, Karim QA.

Lancet. 2011 Dec 17;378(9809):e23-5. doi: 10.1016/S0140-6736(11)61136-7. Epub 2011 Jul 21. No abstract available.

PMID:
21771566
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.

Karim SS, Kashuba AD, Werner L, Karim QA.

Lancet. 2011 Jul 16;378(9787):279-81. doi: 10.1016/S0140-6736(11)60878-7. No abstract available.

PMID:
21763939
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):586-9.

PMID:
22874836
[PubMed - indexed for MEDLINE]
Free Article
11.

Perceptions of emtricitabine-tenofovir in HIV PrEP.

Kruse L, Stover K, Henderson H.

HIV Clin. 2014 Winter;26(1):1, 4-7. No abstract available.

PMID:
24855688
[PubMed - indexed for MEDLINE]
12.

Once-daily dosing and the treatment of HIV disease.

Laurence J.

AIDS Read. 2006 Sep;16(9):444-5. No abstract available.

PMID:
17024761
[PubMed - indexed for MEDLINE]
13.

[Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine].

Boot J, Rump BO, Boucher CA, Op de Coul EL, van Agtmael MA, van de Vijver DA, Burger DM, Fanoy EB.

Ned Tijdschr Geneeskd. 2013;157(27):A6063. Review. Dutch.

PMID:
23838402
[PubMed - indexed for MEDLINE]
14.

A perspective on progress and gaps in HIV prevention science.

Kiser PF, Mesquita PM, Herold BC.

AIDS Res Hum Retroviruses. 2012 Nov;28(11):1373-8. doi: 10.1089/AID.2012.0277.

PMID:
22966871
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

HIV antiretroviral prophylaxis for injecting drug users.

Craig AP, Gray R, Jansson J, Wilson DP.

Lancet. 2013 Sep 7;382(9895):854-5. doi: 10.1016/S0140-6736(13)61856-5. No abstract available.

PMID:
24012263
[PubMed - indexed for MEDLINE]
16.

HIV antiretroviral prophylaxis for injecting drug users.

Hudgens MG, Cole SR.

Lancet. 2013 Sep 7;382(9895):853. doi: 10.1016/S0140-6736(13)61853-X. No abstract available.

PMID:
24012261
[PubMed - indexed for MEDLINE]
17.

HIV antiretroviral prophylaxis for injecting drug users.

Zhiliang H, Yongfeng Y.

Lancet. 2013 Sep 7;382(9895):853-4. doi: 10.1016/S0140-6736(13)61855-3. No abstract available.

PMID:
24012260
[PubMed - indexed for MEDLINE]
18.

Optimizing initial therapy for HIV infection.

Hull MW, Montaner JS.

J Infect Dis. 2011 Oct 15;204(8):1154-6. doi: 10.1093/infdis/jir506. No abstract available.

PMID:
21917886
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants.

Flynn PM, Mirochnick M, Shapiro DE, Bardeguez A, Rodman J, Robbins B, Huang S, Fiscus SA, Van Rompay KK, Rooney JF, Kearney B, Mofenson LM, Watts DH, Jean-Philippe P, Heckman B, Thorpe E Jr, Cotter A, Purswani M; PACTG 394 Study Team.

Antimicrob Agents Chemother. 2011 Dec;55(12):5914-22. doi: 10.1128/AAC.00544-11. Epub 2011 Sep 6.

PMID:
21896911
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

HIV pre-exposure prophylaxis in injecting drug users.

Karim SS.

Lancet. 2013 Jun 15;381(9883):2060-2. doi: 10.1016/S0140-6736(13)61140-X. Epub 2013 Jun 13. No abstract available.

PMID:
23769217
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk